BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Diagnosis
29 results:

  • 1. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.
    Schwarz M; Schwarz C; Burghart L; Pfisterer N; Bauer D; Hübl W; Mandorfer M; Gschwantler M; Reiberger T
    PLoS One; 2023; 18(8):e0290352. PubMed ID: 37616205
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of
    Xu W; Jiang Y; Tao J; Liu Y; Xia Y; Chen C; Jiang X
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37338093
    [No Abstract]    [Full Text] [Related]  

  • 3. The potential prognostic novel markers PIV and PILE score to predict survival outcomes at hepatocellular cancer.
    Karadağ I; Karakaya S; Yılmaz ME; Çakmak Öksüzoğlu ÖB
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7679-7686. PubMed ID: 36314339
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Technology-Oriented Pathway for Auxiliary diagnosis in the Digital Health Age: A Self-Adaptive Disease Prediction Model.
    Hao Z; Ma J; Sun W
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231805
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).
    Merollini KMD; Gordon LG; Ho YM; Aitken JF; Kimlin MG
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.
    Lockart I; Hajarizadeh B; Buckley N; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3515-3523. PubMed ID: 34520088
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Validity of initial cancer diagnoses in the diagnosis Procedure Combination data in Japan.
    Shigemi D; Morishima T; Yamana H; Yasunaga H; Miyashiro I
    Cancer Epidemiol; 2021 Oct; 74():102016. PubMed ID: 34450452
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma.
    Yang MY; Wu F; Fang F; Yang H; Zhang JF; Chen GD; Yang LY
    BMC Cancer; 2021 Jul; 21(1):772. PubMed ID: 34217251
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of Textbook Outcome in Laparoscopic and Open liver Surgery.
    Görgec B; Benedetti Cacciaguerra A; Lanari J; Russolillo N; Cipriani F; Aghayan D; Zimmitti G; Efanov M; Alseidi A; Mocchegiani F; Giuliante F; Ruzzenente A; Rotellar F; Fuks D; D'Hondt M; Vivarelli M; Edwin B; Aldrighetti LA; Ferrero A; Cillo U; Besselink MG; Abu Hilal M
    JAMA Surg; 2021 Aug; 156(8):e212064. PubMed ID: 34076671
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Breast cancers observed in transplant patients in a single institution.
    Anderson TL; Brandts HM; Gunderson T; Fazzio RT; Hunt KN; Heimbach JK; Glazebrook KN
    Clin Imaging; 2021 Aug; 76():26-29. PubMed ID: 33548889
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association between prophylactic antibiotic use for transarterial chemoembolization and occurrence of liver abscess: a retrospective cohort study.
    Yoshihara S; Yamana H; Akahane M; Kishimoto M; Nishioka Y; Noda T; Matsui H; Fushimi K; Yasunaga H; Kasahara K; Imamura T
    Clin Microbiol Infect; 2021 Oct; 27(10):1514.e5-1514.e10. PubMed ID: 33465502
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
    Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN
    J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Application of liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
    Lee S; Kim SS; Bae H; Shin J; Yoon JK; Kim MJ
    Eur Radiol; 2021 Feb; 31(2):855-863. PubMed ID: 32809162
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diabetes, Glycated Hemoglobin, and Risk of cancer in the UK Biobank Study.
    Peila R; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1107-1119. PubMed ID: 32179703
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of liver cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
    Bardou-Jacquet E; Morandeau E; Anderson GJ; Ramm GA; Ramm LE; Morcet J; Bouzille G; Dixon J; Clouston AD; Lainé F; Turlin B; Powell LW; Deugnier YM
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1851-1857. PubMed ID: 31622736
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play?
    Abu Saadeh F; Riain CO; Cormack CM; Gleeson N
    Ir J Med Sci; 2019 May; 188(2):619-624. PubMed ID: 30074141
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
    Luo W; Liao M; Liao Y; Chen X; Huang C; Fan J; Liao W
    World J Surg Oncol; 2018 Feb; 16(1):36. PubMed ID: 29466986
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
    Kawaguchi T; Shima T; Mizuno M; Mitsumoto Y; Umemura A; Kanbara Y; Tanaka S; Sumida Y; Yasui K; Takahashi M; Matsuo K; Itoh Y; Tokushige K; Hashimoto E; Kiyosawa K; Kawaguchi M; Itoh H; Uto H; Komorizono Y; Shirabe K; Takami S; Takamura T; Kawanaka M; Yamada R; Matsuda F; Okanoue T
    PLoS One; 2018; 13(1):e0185490. PubMed ID: 29385134
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
    Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Young patients with synchronous colorectal liver metastases.
    Smith JD; Lowery MA; Fell D; Gallagher DJ; Nash GM; Kemeny NE
    J Surg Oncol; 2016 Apr; 113(5):473-6. PubMed ID: 27110700
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.